This federal contract award, valued at $12,277.98, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services.
The contract does not utilize any set-aside designations and is a firm-fixed-price purchase order with a performance period ending on May 31, 2025. Novocure acts as the prime contractor, delivering its proprietary cancer treatment technologies directly to VA medical centers across the country without the use of subcontractors.
This award is associated with Novocure's larger 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with the VA VHA, which was awarded in November 2022 with a ceiling value of $28.85 million. The FSS contract provides a streamlined procurement vehicle for the VA to efficiently obtain Novocure's Optune TTFields therapy products and services, supporting the agency's mission of expanding veterans' access to cutting-edge cancer therapies.
Generated 2/21/25, 9:02 AM